Key Takeaways
- Shares of Rocket Lab declined 9% during pre-market hours following its Q2 2026 financial results
- The company achieved record quarterly revenue of $234 million, marking a 62% increase year-over-year and exceeding projections
- Forward-looking Q3 GAAP gross margin forecast of 29%–31% significantly underperformed Wall Street’s anticipated ~37.6%
- Prior to the earnings announcement, shares had surged approximately 27% over the previous week, creating conditions for a correction
- Strong fundamentals remain with a $2.36 billion backlog and recent $397 million Space Force contract win
Shares of Rocket Lab experienced a sharp 9% decline in pre-market activity Tuesday following the company’s Q2 2026 earnings release, which raised concerns about future profitability margins.
While the aerospace manufacturer delivered record quarterly revenue of $234 million—representing a 62% year-over-year jump and narrowly surpassing the analyst consensus of $232 million—the positive top-line performance failed to support the share price.
The company reported an adjusted loss of $0.08 per share, falling short of analyst projections. However, the primary concern centered on Q3 guidance, with GAAP gross margin expectations of 29%–31% substantially below Street estimates hovering around 37.6%.
The timing proved particularly unfavorable, as shares had climbed approximately 27% during the week preceding the earnings announcement. This pre-earnings rally left the stock susceptible to selling pressure when profitability metrics disappointed.
Management attributed the margin compression to evolving revenue composition. Specifically, satellite platform sales—which carry lower profit margins—represented an increased proportion of Space Systems segment revenue during the quarter.
The company’s non-GAAP gross margin reached 41.5% in Q2, exceeding the anticipated 38%. Nevertheless, the weaker forward guidance dominated investor sentiment and trading action.
Forward Guidance and Iridium Acquisition Concerns
Company leadership projected Q3 revenue ranging from $250 million to $265 million, significantly surpassing consensus estimates of $235.9 million. Despite the strong revenue outlook, the anticipated margin contraction became the focal point for market participants.
Non-GAAP gross margin expectations for the upcoming quarter stand between 35% and 37%, representing a decline from the current quarter’s 41.5%. The company anticipates an adjusted EBITDA loss of $17 million to $23 million.
The proposed $8 billion Iridium acquisition continues to create additional complexity for investors. Q3 projections incorporate approximately 41 million preferred shares, heightening dilution concerns within the shareholder base.
Selling pressure that began in after-hours trading Monday continued through Tuesday’s pre-market session. Broader market conditions offered minimal support, with both the S&P 500 and Nasdaq trading relatively flat.
Contract Pipeline and Backlog Demonstrate Strength
Rocket Lab concluded the quarter with a record backlog totaling $2.36 billion. The launch manifest currently includes over 90 scheduled missions.
The company secured a significant $397 million contract from the U.S. Space Force last week, encompassing both development and launch services for Flatellite spacecraft utilizing the Neutron rocket platform.
Progress on Neutron continues as planned, with Stage 1 tank production scheduled for delivery to the launch facility in Q4. This represents a critical milestone within the company’s long-term expansion strategy.
Earlier this year, [[LINK_START_2]]Rocket Lab[[LINK_END_2]] finalized acquisitions of both Mynaric and Motiv, expanding its technological capabilities across spacecraft and space systems offerings.
Wall Street analysts maintain a Strong Buy consensus on the stock, with 13 Buy ratings and 4 Hold ratings issued over the past three months. The average price target stands at $110.53, suggesting potential upside of approximately 38% from Monday’s closing price.



